SEC FORM
3
SEC Form 3
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0104 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year)
04/01/2013
|
3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES
[ ABT ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
|
10% Owner |
| X |
Officer (give title below) |
|
Other (specify below) |
|
Senior Vice President
|
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Beneficially Owned |
|---|
| 1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Common shares without par value |
39,148 |
D |
|
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
|
Option (right to buy)
|
02/19/2011 |
02/18/2020 |
Common shares |
4,467 |
26.19 |
D |
|
|
Option (right to buy)
|
02/19/2012 |
02/18/2020 |
Common shares |
4,466 |
26.19 |
D |
|
|
Option (right to buy)
|
02/19/2013 |
02/18/2020 |
Common shares |
4,467 |
26.19 |
D |
|
|
Option (right to buy)
|
02/12/2011 |
02/19/2014 |
Common shares |
587 |
24.73 |
D |
|
|
Option (right to buy)
|
03/15/2011 |
02/19/2014 |
Common shares |
1,443 |
24.72 |
D |
|
|
Option (right to buy)
|
02/18/2012 |
02/17/2021 |
Common shares |
6,334 |
22.39 |
D |
|
|
Option (right to buy)
|
02/18/2013 |
02/17/2021 |
Common shares |
6,333 |
22.39 |
D |
|
|
Option (right to buy)
|
02/18/2014 |
02/17/2021 |
Common shares |
6,333 |
22.39 |
D |
|
|
Option (right to buy)
|
02/17/2013 |
02/16/2022 |
Common shares |
6,534 |
27.03 |
D |
|
|
Option (right to buy)
|
02/17/2014 |
02/16/2022 |
Common shares |
6,533 |
27.03 |
D |
|
|
Option (right to buy)
|
02/17/2015 |
02/16/2022 |
Common shares |
6,533 |
27.03 |
D |
|
|
Option (right to buy)
|
02/15/2014 |
02/14/2023 |
Common shares |
14,300 |
34.94 |
D |
|
|
Option (right to buy)
|
02/15/2015 |
02/14/2023 |
Common shares |
14,300 |
34.94 |
D |
|
|
Option (right to buy)
|
02/15/2016 |
02/14/2023 |
Common shares |
14,300 |
34.94 |
D |
|
| Explanation of Responses: |
|
|
John A. Berry, by Power of Attorney for Charles D. Foltz |
04/03/2013 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Exhibit 24.1
POWER OF ATTORNEY
The undersigned constitutes and appoints HUBERT L. ALLEN,JOHN A.
BERRY and JESSICA H. PAIK,and each of them individually, as the
undersigned's true and lawful attorney-in-fact and agent, with
full power of substitution and re-substitution, for the
undersigned and in the undersigned's name, place and stead,
to prepare and sign any and all Securities and Exchange Commission
("SEC") Notices of Proposed Sales of Securities pursuant to Rule 144
under the Securities Act of 1933 on Form 144, all SEC statements
on Forms 3, 4 and 5 as required under Section 16(a) of the Securities
Exchange Act of 1934, including a Form ID and any other documents
necessary to obtain codes and passwords necessary to make electronic
filings, and any amendments to such forms, and to file the same with
all exhibits thereto, and other documents in connection therewith,
with the SEC, granting unto said attorney-in-fact and agent full
power and authority to do and perform each act and thing requisite,
necessary or desirable to be done under said Rule 144 and Section
16(a), as fully for all intents and purposes as the undersigned
might or could do in person, hereby ratifying and confirming all
that said attorney-in-fact and agent may lawfully do or cause to be
done by virtue hereof.
A copy of this power of attorney shall be filed with the SEC. The
authorization set forth above shall continue in full force and effect
until the undersigned is no longer required to file Forms 144, 3, 4, or
5 or if earlier, until the undersigned revokes such authorization by
written instructions to the attorney-in-fact.
Date: March 28, 2013
/s/ Charles D. Foltz
Signature of Reporting Person
Charles D. Foltz
Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064
